Literature DB >> 16251329

Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates.

Zhifang Xie1, Noman Siddiqi, Eric J Rubin.   

Abstract

We compared the efficacies of 17 agents against rapidly growing and starved Mycobacterium tuberculosis H37Rv. Few compounds have significant activity at attainable concentrations. However, two phenothiazine compounds at similar concentrations were bactericidal for starved and growing cells. These drugs appear to target a process important in both replicating and nonreplicating bacteria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251329      PMCID: PMC1280169          DOI: 10.1128/AAC.49.11.4778-4780.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.

Authors:  Helena I M Boshoff; Timothy G Myers; Brent R Copp; Michael R McNeil; Michael A Wilson; Clifton E Barry
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

2.  Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics.

Authors:  E Tuomanen; A Tomasz
Journal:  Scand J Infect Dis Suppl       Date:  1990

3.  Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria.

Authors:  R H Eng; F T Padberg; S M Smith; E N Tan; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

4.  Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori.

Authors:  M R Millar; J Pike
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling.

Authors:  Joanna C Betts; Pauline T Lukey; Linda C Robb; Ruth A McAdam; Ken Duncan
Journal:  Mol Microbiol       Date:  2002-02       Impact factor: 3.501

6.  Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis.

Authors:  Diane Ordway; Miguel Viveiros; Clara Leandro; Rosário Bettencourt; Josefina Almeida; Marta Martins; Jette E Kristiansen; Joseph Molnar; Leonard Amaral
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 7.  M. tuberculosis persistence, latency, and drug tolerance.

Authors:  James E Gomez; John D McKinney
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

8.  Starvation- and Stationary-phase-induced resistance to the antimicrobial peptide polymyxin B in Salmonella typhimurium is RpoS (sigma(S)) independent and occurs through both phoP-dependent and -independent pathways.

Authors:  G I McLeod; M P Spector
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

9.  Drug tolerance in Mycobacterium tuberculosis.

Authors:  R S Wallis; S Patil; S H Cheon; K Edmonds; M Phillips; M D Perkins; M Joloba; A Namale; J L Johnson; L Teixeira; R Dietze; S Siddiqi; R D Mugerwa; K Eisenach; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

10.  Capreomycin is active against non-replicating M. tuberculosis.

Authors:  Leonid Heifets; Julie Simon; Van Pham
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-04-01       Impact factor: 3.944

View more
  66 in total

1.  The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis.

Authors:  Srinivasa P S Rao; Sylvie Alonso; Lucinda Rand; Thomas Dick; Kevin Pethe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

Review 2.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

3.  Phosphorylation on PstP Regulates Cell Wall Metabolism and Antibiotic Tolerance in Mycobacterium smegmatis.

Authors:  Farah Shamma; Kadamba Papavinasasundaram; Samantha Y Quintanilla; Aditya Bandekar; Christopher Sassetti; Cara C Boutte
Journal:  J Bacteriol       Date:  2021-01-25       Impact factor: 3.490

4.  Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.

Authors:  Claudia Sala; Neeraj Dhar; Ruben C Hartkoorn; Ming Zhang; Young Hwan Ha; Patricia Schneider; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

Review 5.  Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.

Authors:  Yusuke Minato; Joshua M Thiede; Shannon Lynn Kordus; Edward J McKlveen; Breanna J Turman; Anthony D Baughn
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

6.  Intramolecular alpha-glucosaminidation: synthesis of mycothiol.

Authors:  Kehinde Ajayi; Vinay V Thakur; Robert C Lapo; Spencer Knapp
Journal:  Org Lett       Date:  2010-06-04       Impact factor: 6.005

7.  Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.

Authors:  Sang Hyun Cho; Saradee Warit; Baojie Wan; Chang Hwa Hwang; Guido F Pauli; Scott G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

8.  Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery.

Authors:  Sean Ekins; Robert C Reynolds; Hiyun Kim; Mi-Sun Koo; Marilyn Ekonomidis; Meliza Talaue; Steve D Paget; Lisa K Woolhiser; Anne J Lenaerts; Barry A Bunin; Nancy Connell; Joel S Freundlich
Journal:  Chem Biol       Date:  2013-03-21

9.  A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine.

Authors:  Noton K Dutta; Smriti Mehra; Deepak Kaushal
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

10.  Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis.

Authors:  Jansy Sarathy; Véronique Dartois; Thomas Dick; Martin Gengenbacher
Journal:  Antimicrob Agents Chemother       Date:  2013-01-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.